| 2025 | Non-Alcoholic Fatty Liver Disease and Its Association with Kidney and Cardiovascular Outcomes in Moderate to Advanced Chronic Kidney Disease | AMERICAN JOURNAL OF NEPHROLOGY |
| 2025 | BP and Kidney Disease Progression in Advanced CKD Findings from the Chronic Renal Insufficiency Cohort and KoreaN Cohort Study for Outcome in Patients with CKD Studies | CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY |
| 2025 | Genetic Risk for Hypertension Increases the Effect of Salt Intake on the Risk of Incident CKD | CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY |
| 2025 | Plasma Levels of Fibroblast Growth Factor 21 and Adverse Kidney Outcomes | MAYO CLINIC PROCEEDINGS |
| 2025 | Proteinuria Trajectories A Step Forward or Parallel Track in IgA Nephropathy Prediction? | CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY |
| 2025 | Type 2 diabetes mellitus modifies the relationship between coronary artery calcification and adverse kidney outcome in patients with chronic kidney disease: the findings from KNOW-CKD | JOURNAL OF NEPHROLOGY |
| 2025 | Association of accelerometer-measured physical activity with adverse cardiovascular outcomes in individuals with or without chronic kidney diseases: the UK biobank study | JOURNAL OF NEPHROLOGY |
| 2025 | Pyruvate kinase M2 activation maintains mitochondrial metabolism by regulating the interaction between HIF-1α and PGC-1α in diabetic kidney disease
| MOLECULAR MEDICINE |
| 2025 | Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease | NEPHROLOGY DIALYSIS TRANSPLANTATION |
| 2025 | Association between colchicine use and adverse cardiovascular events in patients with gout: a nationwide nested case-control study | RHEUMATOLOGY |
| 2025 | Comment on: Association between colchicine use and adverse cardiovascular events in patients with gout: a nationwide nested case-control study: Reply | RHEUMATOLOGY |
| 2025 | Hospitalization among adults with chronic kidney disease: results from the KoreaN cohort study for Outcomes in patients With Chronic Kidney Disease (KNOW-CKD) study
| KIDNEY RESEARCH AND CLINICAL PRACTICE |
| 2025 | Use of Aspirin and Initial Cardiovascular and Bleeding Risk in Patients with Chronic Kidney Disease | CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY |
| 2025 | Risk factors and transitional probability of clinical events in Korean CKD patients using the multistate model
| SCIENTIFIC REPORTS |
| 2025 | Association between urine creatinine excretion and bone mineral density in chronic kidney disease: Results from the KNOW-CKD study | JOURNAL OF NEPHROLOGY |
| 2025 | Medication Burden and Adverse Cardiovascular Events and Death in Patients Treated with Maintenance Hemodialysis | CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY |
| 2024 | The impact of shortening patient–doctor contact duration on early peritoneal dialysis-related infections | SCIENTIFIC REPORTS |
| 2024 | Association between dietary magnesium intake and incident chronic kidney disease: a prospective observational cohort study | AMERICAN JOURNAL OF CLINICAL NUTRITION |
| 2024 | The role of PCSK9 in glomerular lipid accumulation and renal injury in diabetic kidney disease | DIABETOLOGIA |
| 2024 | Lactobacillus acidophilus KBL409 protects against kidney injury via improving mitochondrial function with chronic kidney disease | EUROPEAN JOURNAL OF NUTRITION |
| 2024 | Phase 1b/2a Study Assessing the Safety and Efficacy of Felzartamab in Anti-Phospholipase A2 Receptor Autoantibody-Positive Primary Membranous Nephropathy
| KIDNEY INTERNATIONAL REPORTS |
| 2024 | Kidney function and bone mineral density in chronic kidney disease patients | CLINICAL KIDNEY JOURNAL |
| 2024 | Multifaceted association of overweight and metabolically unhealthy with the risk of Barrett's esophagus in the UK Biobank cohort
| SCIENTIFIC REPORTS |
| 2024 | Plasma Levels of Polyunsaturated Fatty Acids and Adverse Kidney Outcomes | AMERICAN JOURNAL OF KIDNEY DISEASES |
| 2024 | Adequacy of Dialysis and Incidence of Atrial Fibrillation in Patients Undergoing Hemodialysis | CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES |
| 2024 | Association between progression of coronary artery calcification and development of kidney failure with replacement therapy: Findings from KNOW-CKD study | ATHEROSCLEROSIS |
| 2024 | Difference Between Estimated GFR Based on Cystatin C Versus Creatinine and Incident Atrial Fibrillation: A Cohort Study of the UK Biobank | AMERICAN JOURNAL OF KIDNEY DISEASES |
| 2024 | Volume control strategy and patient survival in sepsis-associated acute kidney injury receiving continuous renal replacement therapy: a randomized controlled trial with secondary analysis
| SCIENTIFIC REPORTS |
| 2024 | Triglyceride-glucose index is an independent predictor of coronary artery calcification progression in patients with chronic kidney disease
| KIDNEY RESEARCH AND CLINICAL PRACTICE |
| 2024 | Presence of periodontal disease and the incidence of inflammatory arthritides in the general population: data from the UK Biobank | RHEUMATOLOGY |
| 2024 | Higher potassium intake is associated with a lower risk of chronic kidney disease: population-based prospective study | AMERICAN JOURNAL OF CLINICAL NUTRITION |
| 2024 | Findings from the KNOW-CKD Study indicate that higher systolic blood pressure time in target range is associated with a lower risk of chronic kidney disease progression | KIDNEY INTERNATIONAL |
| 2024 | Glomerulonephritis following COVID-19 infection or vaccination: a multicenter study in South Korea
| KIDNEY RESEARCH AND CLINICAL PRACTICE |
| 2024 | Association of ketone bodies with incident CKD and death: A UK Biobank study | DIABETES & METABOLISM |
| 2024 | Proteinuria, measured or estimated albuminuria for risk prediction in patients with chronic kidney disease?
| NEPHROLOGY DIALYSIS TRANSPLANTATION |
| 2024 | Deficiency of circadian clock gene Bmal1 exacerbates noncanonical inflammasome-mediated pyroptosis and lethality via Rev-erbα-C/EBPβ-SAA1 axis
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2024 | Sweetened Beverage Intake and Incident Chronic Kidney Disease in the UK Biobank Study
| JAMA NETWORK OPEN |
| 2024 | Metabolically Abnormal Non-Obese Phenotype Is Significantly Associated with All-Cause Mortality in Hemodialysis Patients
| JOURNAL OF CLINICAL MEDICINE |
| 2024 | Association between volume status assessed by bioelectrical impedance analysis, lung ultrasound, or weight change and mortality in patients with sepsis-associated acute kidney injury receiving continuous kidney replacement therapy
| KIDNEY RESEARCH AND CLINICAL PRACTICE |
| 2024 | Nocturnal systolic blood pressure dipping and progression of chronic kidney disease | HYPERTENSION RESEARCH |
| 2023 | Association of Plant Protein Intake With Risk of Incident CKD: A UK Biobank Study | AMERICAN JOURNAL OF KIDNEY DISEASES |
| 2023 | Primary myelofibrosis-related glomerulopathy with renal extramedullary hematopoiesis | JOURNAL OF NEPHROLOGY |
| 2023 | Nutritional and Dietary Management of Chronic Kidney Disease Under Conservative and Preservative Kidney Care Without Dialysis
| JOURNAL OF RENAL NUTRITION |
| 2023 | The 2021 KDIGO blood pressure target and the progression of chronic kidney disease: Findings from KNOW-CKD | JOURNAL OF INTERNAL MEDICINE |
| 2023 | Association between Fiber Intake and Risk of Incident Chronic Kidney Disease: The UK Biobank Study | JOURNAL OF NUTRITION HEALTH & AGING |
| 2023 | Effectiveness of a Smartphone Application for Dietary Sodium Intake Measurement
| NUTRIENTS |
| 2023 | Association of strict targets of systolic blood pressure, low-density lipoprotein cholesterol level with albuminuria in patients with chronic kidney disease | HYPERTENSION RESEARCH |
| 2023 | Predictive performance of the new race-free Chronic Kidney Disease Epidemiology Collaboration equations for kidney outcome in Korean patients with chronic kidney disease
| KIDNEY RESEARCH AND CLINICAL PRACTICE |
| 2023 | Glycemic Control and Adverse Clinical Outcomes in Patients with Chronic Kidney Disease and Type 2 Diabetes Mellitus: Results from KNOW-CKD
| DIABETES & METABOLISM JOURNAL |
| 2023 | Systolic blood pressure, low-density lipoprotein cholesterol levels, and adverse kidney outcome: results from KNOW-CKD | HYPERTENSION RESEARCH |